SERNOVA BIOTHERAPEUTICS INC (SVA.CA) Stock Income Statement
TSX-V:SVA - TSX Venture Exchange - CA81752F1062 - Common Stock - Currency: CAD
| TTM (2022-1-31) | 2021 (2021-10-31) | 2020 (2020-10-31) | 2019 (2019-10-31) | 2018 (2018-10-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 11.24M | 6.94M | 5.26M | 4.01M | 3.71M | |||
| Research and Development | 6.84M | 4.38M | 2.55M | 2.50M | 2.23M | |||
| Selling, General, and Administrative Expenses | 4.08M | 2.29M | 2.48M | 2.00M | 1.47M | |||
| Operating Income | -11.24M | -6.94M | -5.26M | -4.01M | -3.71M | |||
| Interest Income/Expense | 300.03K | 20.00K | 20.00K | 40.00K | 10.00K | |||
| Other Income/Expense | N/A | -50.00K | -80.00K | N/A | N/A | |||
| Income Before Taxes | -10.94M | -6.97M | -5.32M | -3.97M | -3.70M | |||
| Income Tax | N/A | N/A | 0.00 | N/A | N/A | |||
| Net Income | -10.94M | -6.97M | -5.32M | -3.97M | -3.70M | |||
| EBITDA | -10.94M | -6.67M | -5.03M | -3.95M | -3.65M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.04 | -0.03 | -0.03 | -0.02 | -0.02 | |||
| Statistics | ||||||||
All data in CAD